Tag: ALK inhibitor

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to ALK inhibitor

Emera Incorporated (EMA) Analysts See $0.63 EPS

Added to Collection on: 2019-01-05 08:00:00

Tags for this article:

Chemistry
Organic chemistry
Piperidines
Pyrimidines
Protein kinase inhibitors
Pyridines
Anaplastic lymphoma kinase
Emera
Brentuximab vedotin
Crizotinib
Brigatinib
ALK inhibitor

Click the tags to see associated articles and topics

View Article Details
US FDA Expands Approval of Pfizer's LORBRENA® as First-Line Treatment for ALK-Positive ...

Added to Collection on: 2021-03-04 00:00:00

Tags for this article:

Chemical compounds
Organic compounds
Piperidines
Breakthrough therapy
Protein kinase inhibitors
Tyrosine kinase receptors
Lung cancer
Lorlatinib
ALK inhibitor
Ceritinib
Anaplastic lymphoma kinase
ROS1
XALKORI
Pfizer Inc.
Alectinib
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
U.S. FDA Expands Approval of Pfizer's LORBRENA® as First-Line Treatment for ALK-Positive ...

Added to Collection on: 2021-03-04 14:44:28

Tags for this article:

Chemical compounds
Organic compounds
Piperidines
Breakthrough therapy
Protein kinase inhibitors
Tyrosine kinase receptors
Lung cancer
Lorlatinib
Ceritinib
ALK inhibitor
Anaplastic lymphoma kinase
ROS1
XALKORI
Pfizer Inc.
Alectinib
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Pfizer's Lorbrena breaks into front-line ALK lung cancer, jostling with Novartis, Roche and Takeda

Added to Collection on: 2021-03-04 15:45:00

Tags for this article:

Chemical compounds
Piperidines
Organic compounds
Chemistry
Protein kinase inhibitors
Breakthrough therapy
Orphan drugs
Lung cancer
Ceritinib
Crizotinib
ALK inhibitor
Anaplastic lymphoma kinase
Pfizer
XALKORI
Lorbrena
PFIZER'S

Click the tags to see associated articles and topics

View Article Details
FDA Approves CDx for Lorlatinib in ALK-Positive Non–Small Cell Lung Cancer

Added to Collection on: 2021-03-09 19:07:21

Tags for this article:

Chemical compounds
Organic compounds
Chemistry
Piperidines
Breakthrough therapy
Protein kinase inhibitors
Lung cancer
Orphan drugs
ALK inhibitor
Ceritinib
Anaplastic lymphoma kinase
Lorlatinib
Roche

Click the tags to see associated articles and topics

View Article Details
Scientists uncover four proteins that govern the identity of anaplastic large cell lymphoma

Added to Collection on: 2024-03-22 23:29:41

Tags for this article:

Lymphoma
Gene expression
Signal transduction
Anaplastic large-cell lymphoma
Non-Hodgkin lymphoma
Immune system
Anaplastic lymphoma kinase
T-cell lymphoma
STAT3
ALK inhibitor
Super-enhancer
Tyrosine kinase
Mark Zimmerman

Click the tags to see associated articles and topics

View Article Details
FDA approves Roche's Alecensa as the first adjuvant treatment for people with ALK ... - 新浪香港

Added to Collection on: 2024-04-19 17:46:20

Tags for this article:

Lung cancer
Tyrosine kinase receptors
Orphan drugs
Cancer treatments
Alectinib
Ketones
Anaplastic lymphoma kinase
Non-small-cell lung cancer
ALK inhibitor
Brain metastasis
Genentech
Protein kinase inhibitor
Roche Group
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
FDA Approves Roche?s Alecensa as the First Adjuvant Treatment for People with ALK ...

Added to Collection on: 2024-04-19 15:08:37

Tags for this article:

Lung cancer
Piperidines
Tyrosine kinase receptors
Alectinib
Ketones
Nitriles
ALK inhibitor
Anaplastic lymphoma kinase
Non-small-cell lung cancer
Protein kinase inhibitor
ALK positive lung cancer
Ceritinib

Click the tags to see associated articles and topics

View Article Details
Alecensa Approved by FDA as the First Adjuvant Treatment for People with ALK-Positive ...

Added to Collection on: 2024-04-19 14:33:35

Tags for this article:

Lung cancer
Cancer treatments
Tyrosine kinase receptors
Alectinib
Ketones
Nitriles
Anaplastic lymphoma kinase
Non-small-cell lung cancer
Anaplastic large-cell lymphoma
ALK inhibitor
Adjuvant therapy
Protein kinase inhibitor
Chugai Pharmaceutical Co. Ltd
Japan
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Book a Demo